MedTrace Logo

Identify Clinical Conditions That Increase Circulating DNA Levels

NCT01815996 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 130

Last updated 2018-11-21

No results posted yet for this study

Summary

The investigators are developing a test that is expected to measure the amount of radiation a patient has been exposed to after a nuclear bomb. The investigator will do this by measuring the DNA in the patients blood from cells killed by the radiation.

Many diseases and medical conditions can put DNA in the blood. The investigator needs to know how much DNA in order to better interpret our radiation detection test. Therefore, the investigator is collecting blood from several patients with different diseases or medical conditions and also healthy volunteers to measure their DNA content.

Patients that will be included in this study are pregnant women, patients who have suffered a pulmonary embolism within the past 48 hours, patients who have suffered from myocardial infarction in the past 48 hours, patients with autoimmune diseases and health patients.

Conditions

Interventions

OTHER

One time blood draw to look at patient's DNA

One time blood draw to look at patient's DNA

Sponsors & Collaborators

  • University of Florida

    lead OTHER

Principal Investigators

  • Paul Okunieff, MD · University of Florida

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2016-07-28
Completion
2016-07-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01815996 on ClinicalTrials.gov